Irritable
Bowel Syndrome (IBS): Clinical approach in Family
Practice
.........................................................................................................................
Dr.
Firdous Jahan
Assistant Professor, Family Medicine Dept.
Aga Khan University Hospital, Karachi, Pakistan
Correspondence:
Email: firdous.jahan@aku.edu
IBS is a chronic, relapsing gastrointestinal
problem, characterized by abdominal pain, bloating,
and changes in bowel habit.(1) While the precise
prevalence and incidence depends on the criteria
used, all studies agree that it is a common
disorder, affecting a substantial proportion
of individuals in the general population and
presenting frequently to general practitioners
and to specialists.(2) IBS is troublesome, with
a significant negative impact on quality of
life and social functioning in many patients.(3,4)
IBS generates significant health care costs.
Approximately two thirds of IBS patients referred
to secondary care show some form of psychological
distress, most commonly anxiety. Diagnosing
a patient who presents with abdominal pain and
altered bowel habits can be challenging.(5)
IBS also accounts for a significant number of
visits to primary care physicians and is the
second highest cause of absenteeism after the
common cold. Approaches to managing IBS should
be informed by psychological understanding,
recognizing that the most important aspect of
management is the relation between the patient
and the physician.(6,7) Patients with IBS managed
in primary care comprise the entire spectrum,
from those with mild or ill defined symptoms
to those with severe or persistent problems.
The mind and body often combine to increase
the misery of IBS patients.(8)
Normal motility, or movement, may not be present
in the colon of a person who has IBS. It can
be spasmodic or can even stop working temporarily.
The lining of the colon, which is affected by
the immune and nervous systems, regulates the
flow of fluids in and out of the colon. When
the contents inside the colon move too quickly,
the colon loses its ability to absorb fluids.
The result is too much fluid in the stool. In
others, the movement inside the colon is too
slow, which causes extra fluid to be absorbed.
As a result, a person develops constipation.
(9) A person's colon may respond strongly to
stimuli such as certain foods or stress that
would not bother most people. Small-bowel motor
dysfunction with concomitant gastro paresis
occurs more frequently in patients with IBS.
Serotonin is a neurotransmitter, or chemical,
that delivers messages from one part of the
body to another. (10) People with IBS, however,
have diminished receptor activity, causing abnormal
levels of serotonin to exist in the GI tract.
Stimulation of various chemo receptors and mechanoreceptors
in the gut wall transmit signals via afferent
neural pathways to the dorsal horn of the spinal
cord and ultimately to the brain .(11,28)
IBS may be caused by a bacterial infection in
the gastrointestinal tract. Studies show that
people who have had gastroenteritis sometimes
develop IBS, otherwise called post-infectious
IBS. The development of irritable bowel syndrome
following infectious enteritis has been suspected
clinically based upon a history of an acute
diarrheal illness preceding the onset of irritable
bowel symptoms in some pathogens included Escherichia
coli O157:H7 and Campylobacter jejuni.(13) In
severe infection, disruption of mucosal nerves
may lead to irritability development of idiopathic
bile acid malabsorption and increase in entero
endocrine cells, T lymphocytes, and gut permeability
has been demonstrated following acute Campylobacter
enteritis, these changes persist for more than
one year. Antibiotics may develop diarrhea related
to alteration in colonic flora which will lead
to reduced disaccharidase activity resulting
in malabsorption of dietary sugars. Occult inflammatory
bowel disease may have developed following infection.
Microbes such as Lactobacillus strains may regulate
immune responses directly in the host. Selective
deficiencies of intestinal lactobacilli and
bifidobacteria have been described in patients
with Crohn's disease and IBS.(12)
IBS is generally diagnosed on the basis of a
complete medical history that includes a careful
description of symptoms and a physical examination.(14)
Relevant history includes change in frequency
of bowel movements, a change in appearance of
bowel movements, feelings of uncontrollable
urgency to have a bowel movement, difficulty
or inability to pass stool, mucus in the stool
and bloating. The following have been associated
with a worsening of IBS symptoms: large meals,
bloating from gas in the colon, medicines ,wheat,
rye, barley, chocolate, milk products, alcohol
drinks, caffeine, such as coffee, tea, or colas,
stress, conflict, or emotional upsets. Women
with IBS may have more symptoms during their
menstrual periods, suggesting that reproductive
hormones can worsen IBS problems.(12) Drinking
carbonated beverages, such as sodas, may result
in gas and cause discomfort. Chewing gum and
eating too quickly can lead to swallowing air,
which also leads to gas.(15,16)
In addition, people with IBS frequently suffer
from depression and anxiety, which can worsen
symptoms. (17) Similarly, the symptoms associated
with IBS can cause a person to feel depressed
and anxious. Stress, feeling mentally or emotionally
tense, troubled, angry, or overwhelmed, can
stimulate colon spasms in people with IBS.(18)
The colon has many nerves that connect it to
the brain. Like the heart and the lungs, the
colon is partly controlled by the autonomic
nervous system, which responds to stress. These
nerves control the normal contractions of the
colon and cause abdominal discomfort at stressful
times .(19)
Although psychiatric illness often coexists
with IBS, a clear causal relationship has not
been shown. IBS might be a precursor to psychiatric
illness; anxiety, major depression, panic disorder,
social phobia, somatization disorder, and dysthymia
have been identified in more than 50 percent
of patients with IBS. IBS is more common in
patients who abuse alcohol and in patients who
have experienced physical or sexual abuse.(12)
Many patients with IBS had stressful life events,
such as divorce or a death in the family, before
they developed symptoms. IBS among patients
with chronic fatigue syndrome, fibromyalgia,
and temporomandibular joint pain syndrome are
high.(20,21)
To date, no gold standard or marker for IBS
exists. A cost-effective diagnostic approach
that uses the fewest tests and invasive studies
is most desirable. As in all illnesses, the
most valuable initial tools are a detailed history
and physical examination. If alarm symptoms
that suggest an underlying organic disease are
uncovered, further testing usually is considered.(22)
Scoring methods, subgroup classifications, laboratory
studies, endoscopy, and psychiatric assessment
are available to help guide the diagnosis in
patients who present with abdominal pain. Several
scoring systems for diagnosing IBS have been
proposed. These scoring systems, which still
are being validated, are useful for research
and can help guide the diagnostic evaluation.
The Rome III Criteria are the current standard
for this definition. (23)
The Rome diagnostic criteria of Irritable Bowel
Syndrome always presumes the absence of a structural
or biochemical explanation for the symptoms
and is made only by a physician.
Irritable Bowel Syndrome can be diagnosed based
on at least 12 weeks (which need not be consecutive)
in the preceding 12 months, of abdominal discomfort
or pain that has two out of three of these features:
1. Relieved with defecation; and/or
2. Onset associated with a change in frequency
of stool; and/or
3. Onset associated with a change in form (appearance)
of stool.
Symptoms that Cumulatively Support the Diagnosis
of IBS:
Abnormal stool frequency (may be defined as
greater than 3 bowel movements per day and less
than 3 bowel movements per week);abnormal stool
form (lumpy/hard or loose/watery stool); abnormal
stool passage (straining, urgency, or feeling
of incomplete evacuation); passage of mucus;
bloating or feeling of abdominal distension.
Patient subgroups (constipation-predominant,
diarrhea-predominant, and pain-predominant),
can be clinically useful IBS-----D (diarrhea),IBS-----C
(constipation), IBS-----M (mixed), IBS-----A
(alternator).(12)
Red Flag symptoms which are NOT typical of
IBS are pain that often awakens/interferes with
sleep, diarrhea that often awakens/interferes
with sleep, blood in stool (visible or occult),
weight loss, fever, abnormal physical examination,
anemia, chronic severe diarrhea and family history
of colon cancer. Patients with alarm features
should undergo the appropriate endoscopic, stool,
and radiologic testing and referral to gastroenterologist.(24)
Many illnesses share some of the same symptoms
as IBS. Some of these illnesses are serious
and require aggressive evaluation and treatment.
Differential diagnosis for patients who present
with abdominal pain and altered bowel habits
are celiac disease, colitis, Giardiasis, lactose/bile
salt malabsorption, tropical sprue, small bowel
bacterial over growth, carcinoma of the colon.(25)
Extra intestinal symptoms include impaired sexual
function, dysmenorrhea, dyspareunia, and increased
urinary frequency and urgency. They are also
more likely to have hypertension, reactive airway
disease, and rheumatologic syndromes, including
fibromyalgia, non cardiac chest pain.(26,27)
Laboratory Tests: Most authors suggest
that all symptomatic patients should have a
complete blood cell count. Determination of
the erythrocyte sedimentation rate, thyroid-stimulating
hormone (TSH) level, and electrolyte levels.
Fecal occult blood testing and the testing of
stool for ova and parasites are useful in patients
with diarrhea. Lactose-malabsorption studies
have limited value except in patients with diarrhea-predominant
symptoms. Second line investigations includes
routine flexible sigmoidoscopy and biopsy, lactose
breath hydrogen test, Endomyseal antibody, tissue
Transglutaminase antibody.(12)
Management in Primary care:
A caring doctor-patient relationship is the
first step in management.
Explaining the diagnosis should be followed
by reassurance as there is no single etiology
and patients visit the physician with recurring
symptoms.(28)
Avoiding aggravating factors including certain
drugs and diet.
The treatment plan is based on the nature and
severity of the symptoms, the degree of functional
impairment, and the presence of psychosocial
factors .Because of its safety and low cost,
a trial of fiber is reasonable; particularly
in patients whose predominant symptom is constipation.(29)
At low dosages, tricyclic antidepressants (TCAs)
and, potentially, selective serotonin reuptake
inhibitors (SSRIs) have analgesic properties
independent of their effect on mood. The anti
cholinergic properties of TCAs may slow intestinal
transit time, making them effective in the treatment
of diarrhea. Fiber supplements or laxatives
for constipation or medicines decrease diarrhea,
such as loperamide .(12) An antispasmodic is
commonly prescribed, which helps to control
colon muscle spasms and reduce abdominal pain.
However, both antispasmodics and antidepressants
can worsen constipation. Medications affect
people differently, and no one medication or
combination of medications will work for everyone
with IBS.(12,30)
Probiotics are live microbial food supplements
or components of bacteria that alter the enteric
micro flora. The most frequently used genera
are Lactobacilli and Bifidobacteria. The potential
mechanisms of their action include competitive
bacterial interactions, production of antimicrobial
metabolites, mucosal conditioning, and immune
modulation.(31)
Peppermint leaves contain oils that have mild
anesthetic properties, relieve nausea, and relax
smooth muscle spasticity caused by histamine
and cholinergic stimulation. The herb ginger
has one component, gingerois, which functions
as a serotonin 5-HT antagonist and enhances
motility. Aloe Vera has been recommended for
constipation-dominant IBS. Fennel has been recommended
for IBS-related bloating.(32,33)
A variety of psychotherapies, including cognitive
behavior therapy, hypnosis, and stress management/relaxation
therapy, reduce abdominal pain and diarrhea.(34)
Relaxation technique is the process, procedure,
or activity that helps a person to relax, including
autogenic training, biofeedback, deep breathing,
meditation, progressive muscle relaxation, visualization,
yoga and hypnosis.(35) Stress management is
an important part of treatment for IBS. Frequent
and regular meditation and relaxation, even
if only for a few minutes a day, does four things
that are helpful in a stress-reducing program:
it trains the attention, increases control over
thought processes, increases the ability to
handle emotions and aids physical relaxation.
Physical activity is a way of responding to
stress which allows the discharge of the energy
the body is anticipating. Physical activity
can be taken in many ways, including activities
such as walking, jogging or sport.(36)
Progressive muscle relaxation teaches patients
to relax muscles through a two-step process,
first deliberately apply tension to certain
muscle groups, and then stop the tension and
turn your attention to noticing how the muscles
relax as the tension flows away. Cognitive therapy
seeks to help the patient overcome difficulties
by identifying and changing dysfunctional thinking,
behavior, and emotional responses. Identified
"problem cycle," and the efforts of
the therapist and patient would be directed
at working together to change it and also address
the way the patient thinks and behaves in response
to similar situations and by doing develop more
flexible ways to think and respond .(37) The
patient may then become more active, succeed
and respond more adaptively more often, and
further reduce or cope with his negative feelings.
The mind and body often combine to increase
the misery of IBS patients. Psychological interventions
including cognitive behavioral therapy, hypnotherapy
and relaxation techniques are worth considering.
A great majority of IBS patients can be managed
well by Family Physicians .(37,38) Awareness
of 'red flags' for referral to a specialist
gastroenterologist is a must. If handled properly,
stress can help improve performance, but too
much stress without appropriate strategy to
control it can be harmful for the mind and the
body.(39,40) Given the limited benefits of pharmacologic
therapy and the psychosocial issues involved,
effective treatment of IBS requires a comprehensive,
multifaceted approach.(41,42)
1. Casiday, R. E, Hungin, A P S, Cornford,
C. S, de Wit, N. J, Blell, M. T . Patients'
explanatory models for irritable bowel syndrome:
symptoms and treatment more important than
explaining aetiology. Fam Pract 2009;26: 40-47.
2. W G Thompson, K W Heaton, G T Smyth, C
Smyth. Irritable bowel syndrome in general
practice: prevalence, characteristics, and
referral Gut 2000;46:78-82 .
3. Jafri W, Yakoob J, Jafri N. Irritable Bowel
Syndrome in Health Care Professionals in Pakistan
J Pak Med Assoc Sep 2003;53(9):405-7.
4. Fatima Mahboob. Presentation of Irritable
Bowel Syndrome in Medical Outpatient Department
of a Tertiary Care Hospital .Ann King Edward
Med Coll Oct - Dec 2002;8(4):278-9.
5. Tahir Siddique, Maratab Ali, Safdar Hussain
Qadri. Irritable bowel syndrome in two different
socioecnomic groups in Pakistan. Ann King
Edward Med Coll Jan - Mar 2007;13(1):65-6.
6. Fass R, Longstreth GF, Pimentel M, Fullerton
S, Russak SM, Chiou CF, et al. Evidence- and
consensus-based practice guidelines for the
diagnosis of irritable bowel syndrome. Arch
Intern Med 2001; 161:2081-8.
7. Aaron LA, Burke MM, Buchwald D. Overlapping
conditions among patients with chronic fatigue
syndrome, fibromyalgia, and temporomandibular
disorder. Arch Intern Med 2000;160:221.
8. Horwitz BJ, Fisher RS. The irritable bowel
syndrome. N Engl J Med 2001;344:1846-50.
9. Casiday, R. E, Hungin, A., Cornford, C.
S, de Wit, N. J, Blell, M. T . GPs' explanatory
models for irritable bowel syndrome: a mismatch
with patient models?. Fam Pract 2009;26: 34-39
10. Ford, A. C., Talley, N. J., Veldhuyzen
van Zanten, S. J. O., Vakil, N. B., Simel,
D. L., Moayyedi, P. Will the History and Physical
Examination Help Establish That Irritable
Bowel Syndrome Is Causing This Patient's Lower
Gastrointestinal Tract Symptoms? JAMA 2008;300:
1793-1805.
11. Yale, S. H., Musana, A. K., Kieke, A.,
Hayes, J., Glurich, I., Chyou, P.-H. Applying
Case Definition Criteria to Irritable Bowel
Syndrome. Clin Med Res2008; 6: 9-16.
12. Spiller, R, Aziz, Q, Creed, F, Emmanuel,
A, Houghton, L, Hungin, P, Jones, R, Kumar,
D, Rubin, G, Trudgill, N, Whorwell, P . Guidelines
on the irritable bowel syndrome: mechanisms
and practical management. Gut 2007;56: 1770-1798.
13. Neal, K R, Barker, L, Spiller, R C . Prognosis
in post-infective irritable bowel syndrome:
a six year follow up study. Gut 2002;51: 410-413.
14. Rubin, G., Wit, N. D., Meineche-Schmidt,
V. Seifert, B., Hall, N., Hungin, P. The diagnosis
of IBS in primary care: consensus development
using nominal group technique. Fam Pract 2006;
23: 687-692.
15. Robinson, A, Lee, V, Kennedy, A, Middleton,
L, Rogers, A, Thompson, D G, Reeves, D . A
randomised controlled trial of self-help interventions
in patients with a primary care diagnosis
of irritable bowel syndrome. Gut 2006;55:
643-648.
16. Lembo, A. J. . A 54-Year-Old Woman with
Constipation-Predominant Irritable Bowel Syndrome.
JAMA2006; 295: 925-933
17. Spiller, R. C. Irritable bowel syndrome.
Br Med Bull 2005; 72: 15-29.
18. Longstreth, G. F, Burchette, R. J . Family
practitioners' attitudes and knowledge about
irritable bowel syndrome: Effect of a trial
of physician education. Fam Pract 2003; 20:
670-674.
19. Halder, S. L., McBeth, J., Silman, A.
J, Thompson, D. G, Macfarlane, G. J . Psychosocial
risk factors for the onset of abdominal pain.
Results from a large prospective population-based
study. Int J Epidemiol2002; 31: 1219-1225.
20. Guthrie, E., Thompson, D. ABC of psychological
medicine: Abdominal pain and functional gastrointestinal
disorders. BMJ 2002;325: 701-703 .
21. Longstreth GF, Thompson WG, Chey WD, et
al. Functional bowel disorders. Gastroenterology.
2006;130:1480-1491.
22. Drossman DA, Morris CB, Hu Y, et al. A
prospective assessment of bowel habit in irritable
bowel syndrome in women: Defining an alternator.
Gastroenterology. 2005;128:580-589.
23. Drossman DA, moderator. AGA Clinical Symposium
-- Rome III: New Criteria for the Functional
GI Disorders. Program and abstracts of Digestive
Disease Week; May 20-25, 2006; Los Angeles,
California.
24. Tillisch K, Labus JS, Naliboff BD, et
al. Characterization of the alternating bowel
habit subtype in patients with irritable bowel
syndrome. Am J Gastroenterol. 2005;100:896-904.
25. Mertz HR. Irritable bowel syndrome. N
Engl J Med 2003;349: 2136-46.
26. Wasim Jafri, Javed Yakoob, Nadim Jafri,
Muhammad Islam, Qazi Masroor Ali. Irritable
bowel syndrome and health seeking behaviour
in different communities of Pakistan. J Pak
Med Assoc Jun 2007;57(6):285-7.
27. Kassab Harfoushi.Women with irritable
bowel syndrome according to Rome II criteria
in Jordan Pak J Med Sci Jan - Mar 2008;24(1):136-41.
28. Abdullah M. Irritable bowel syndrome:
current review on pathophysiology and diagnotic
aspects. Acta Med Indones Oct 2008;40(4):218-25.
29. Talley NJ, Spiller R. Irritable bowel
syndrome: a little understood organic bowel
disease? Lancet 2002;360:555-64.
30. Brandt LJ, Bjorkman D, Fennerty MB, Locke
GR, Olden K, Peterson W, et al. Systematic
review on the management of irritable bowel
syndrome in North America. Am J Gastroenterol
2002;97(11 suppl):S7-26.
31. Whorwell PJ,Altringer l,Morel J.et al.
Efficacy of an encapsulated probiotic Bifidobacterium
infantis 35624 in women with irritable bowel
syndrome. Am J Gastroenterol 2006;101:1581-90.
32. Madisch A,Holtmann G, Plein K etal. Treatment
of irritable bowel syndrome with herbal prepration.
Aliment PharmacolTher 2004;19:271-9.
33. Spanier JA, Howden CW, Jones MP . A systematic
review of alternative therapies in the irritable
bowel syndrome. Arch Intern Med 2003;163:265-74.
34. Clouse RE,Lustman PJ . Use of psychopharmacological
agents for functional gastrointestinal disorders.
Gut 2005;54:1332-41.
35. Kerse N, Elley CR, Robinson E, et al .
Is physical activity counseling effective
for older people? A cluster randomized, controlled
trial in primary care. J Am Geriatr Soc 2005;53:1951-6.
36. Viera AJ, Hoag S , Shaughnessy J . Management
of irritable bowel syndrome. Am Fam Physician
2002;66:1867-74.
37. Drossman DA, Toner BB, Whitehead WE, Diamant
NE, Dalton CB, Duncan S, et al. Cognitive-behavioral
therapy versus education and desipramine versus
placebo for moderate to severe functional
bowel disorders. Gastroenterology 2003;125:19-31.
38. Javed Iqbal Farooqi, Rukhsana Javed Farooqi.
A New Era in the Management of Irritable Bowel
Syndrome. J Coll Physicians Surg Pak Sep 2001;11(9):585-91.
39. Simren, M., Ringstrom, G., Bjornsson,
E. S., Abrahamsson, H. Treatment With Hypnotherapy
Reduces the Sensory and Motor Component of
the Gastrocolonic Response in Irritable Bowel
Syndrome. Psychosom 2004; Med. 66: 233-238.
40. Creed F, Ratcliffe J, Fernandez L, et
al . Health-related quality of life and health
care costs in severe, refractory irritable
bowel syndrome. Ann Intern Med 2001;134:860-8.
41. Bray BD, Nicol F, Penman ID, et al . Symptom
interpretation and quality of life in patients
with irritable bowel syndrome. Br J Gen Pract
2006;56:122-6.
|